CGEM
Price
$7.65
Change
-$0.12 (-1.54%)
Updated
Jul 18, 03:28 PM (EDT)
Capitalization
458.54M
20 days until earnings call
GOSS
Price
$1.70
Change
-$0.01 (-0.58%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
388.69M
25 days until earnings call
Interact to see
Advertisement

CGEM vs GOSS

Header iconCGEM vs GOSS Comparison
Open Charts CGEM vs GOSSBanner chart's image
Cullinan Therapeutics
Price$7.65
Change-$0.12 (-1.54%)
Volume$113
Capitalization458.54M
Gossamer Bio
Price$1.70
Change-$0.01 (-0.58%)
Volume$5.3K
Capitalization388.69M
CGEM vs GOSS Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. GOSS commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and GOSS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (CGEM: $7.77 vs. GOSS: $1.71)
Brand notoriety: CGEM and GOSS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 73% vs. GOSS: 281%
Market capitalization -- CGEM: $458.54M vs. GOSS: $388.69M
CGEM [@Biotechnology] is valued at $458.54M. GOSS’s [@Biotechnology] market capitalization is $388.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileGOSS’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • GOSS’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 4 TA indicator(s) are bullish while GOSS’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 4 bullish, 4 bearish.
  • GOSS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CGEM and GOSS are a good buy in the short-term.

Price Growth

CGEM (@Biotechnology) experienced а -0.89% price change this week, while GOSS (@Biotechnology) price change was +25.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.78%. For the same industry, the average monthly price growth was +13.32%, and the average quarterly price growth was +34.85%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 06, 2025.

GOSS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($459M) has a higher market cap than GOSS($389M). GOSS YTD gains are higher at: 89.034 vs. CGEM (-36.207). GOSS has higher annual earnings (EBITDA): -35.7M vs. CGEM (-208.62M). CGEM has more cash in the bank: 304M vs. GOSS (258M). CGEM has less debt than GOSS: CGEM (1.84M) vs GOSS (203M). GOSS has higher revenues than CGEM: GOSS (125M) vs CGEM (0).
CGEMGOSSCGEM / GOSS
Capitalization459M389M118%
EBITDA-208.62M-35.7M584%
Gain YTD-36.20789.034-41%
P/E RatioN/AN/A-
Revenue0125M-
Total Cash304M258M118%
Total Debt1.84M203M1%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMGOSS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPNGY32.440.70
+2.21%
MEITUAN
BREUF11.150.09
+0.81%
Bridgemarq Real Estate Svc Inc.
TOPPY13.55N/A
N/A
TOPPAN HOLDINGS INC.
UHOIF12.02N/A
N/A
Ushio Inc.
CLRSF0.04N/A
N/A
CASTILE RES LTD.